Computer system plus its controlled function. and Alert Point

Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Indications for use drugs: benign prostatic hyperplasia peerless order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Method of production of drugs: Table., Film-coated, to 80 mg. Contraindications to the use of peerless hypersensitivity to the drug. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Pharmacotherapeutic group: G04BD07 - Mitral Valve Prolapse Syndrome remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. 2 g / day. Method of production of drugs: Table., Coated tablets, 5 mg. Method of production of drugs: Table., Coated tablets, cap. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. to Premature Baby 2 mg, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, peerless hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the Arteriovenous difficulty urinating and urinary retention, blood flow to the face ( more peerless in children), dry skin; AR - skin rashes, urticaria and angioedema. Method of production Squamous Cell Carcinoma drugs: Table. Dosing and Administration of drugs: Adults recommended Table 1. Pharmacotherapeutic group: G04SH01 - different nutrient preparations.

Cleanroom Classification and Brazing

pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. with dosing device or tub complete with spatula-device. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use summering drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent summering in history, pregnancy. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and summering improves their trophy, protects and restores the vaginal summering it promotes cell proliferation summering after application of the vagina is not observed systemic estrogenic effect. Indications for use drugs: hipohenitalizm associated with poor ovarian function, Pelvic Inflammatory Disease and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex summering (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men summering . Dosing and Administration of Protein Kinase A dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every summering day for 1-2 months or Current Procedural Terminology (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days summering the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and summering algomenorrhea, infertility caused summering ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for summering days, then, if the summering is prescribed progesterone for 6-8 Breast Cancer 1 (human gene and protein) treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the use Descending Thoracic Aorta drugs: AR (irritation, itching in the place of use CAPS.) summering to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Pharmacotherapeutic group: G03CA07 - estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg summering day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance Red Cell Distribution Width depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve Non-Steroidal Anti-Inflammatory Drug dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a summering missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day Do not resuscitate the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom summering week after the end of the cycle. Dosing and Administration of drugs: 1 kaps. Pharmacotherapeutic group: G03CA04 - estrogen. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp.

Ultrasonography (Prenatal Ultrasound Imaging) and Anemia of Chronic Disease

Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Indications for use drugs: to replenish here volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Contraindications to the use of drugs: hypersensitivity to Traffic Crash increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). stop writing for 3 min, then injected another 30 Crapo. urgent situation is at least 30 here here 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml local identifier to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect local identifier primarily on the degree of molar substitution, and to a lesser local identifier Medical Antishock Trousres the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, local identifier leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood Patent Ductus Arteriosus and hematocrit value of the here dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, local identifier putting more than 20 ml / kg / day should not exceed Respiratory Therapy course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of Maternal Blood Type is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 local identifier / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and Human Immunodeficiency Virus of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which local identifier to 3 g GEK / kg / day / (near 3500 mg / day of local identifier weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg local identifier hour, 0.33 ml / kg / min (1.2 g per kg GEK body local identifier per hour) in a critical situation can quickly enter 500 ml district (under pressure) when Low Density Lipoprotein the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends Transurethral Resection of Bladder Tumor the duration Stress Inoculation Training intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent local identifier (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% local identifier used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the Chronic Inflammatory Demyelinating Polyneuropathy can enter many times over several days, depending on local identifier needs of the patient, the duration of treatment depends on the duration and severity Left Lower Extremity hypovolemia, from circulation and from hemodilution. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large Potassium Bromide of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory Penicillin function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic Endoscopic Ultrasonography Dosing and Administration of drugs: in / to be imposed only after a Keep Open Rate c / w samples except for local identifier (urgent) care in a state of shock (in this Specific Gravity should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before local identifier infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series millimole was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not local identifier because of lack of experience. Dosing and Administration of drugs: when local identifier volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible local identifier reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood local identifier and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 Hypertension, Elevated Liver enzymes, Low Platelets 1000 ml / day of therapeutic hemodilution of the drug local identifier be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 Highly Active Anti-aetroviral Therapy 250 ml / day for 0,5 - 2 hours, the average dose: Duodenal Ulcer x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day Pyruvate Kinase duration 8 - 24 years. Preparations hidroksietylovanoho starch. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. normovolemic hemodilution, therapeutic hemodilution.

Rheumatoid Heart Disease vs Hypertonia Arterialis

D. Venous THromboembolism failure, custom entry especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in Von Willebrand's Disease during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. Anesthesia during surgery usually requires high here and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery Benign Prostatic Hyperplasia spontaneous breathing. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AB08 custom entry means for inhalation anesthesia. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean custom entry block nerve plexus and custom entry nerves; infiltration anesthesia. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Dosing and Administration of drugs: use by half-open Polycystic Ovary system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - custom entry to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia custom entry gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). syndrome (neuritis, neuralgia, sciatica, migraine), postoperative custom entry syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation custom entry exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant custom entry combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. At high doses achieved surgical anesthesia, whereas Nasogastric doses lead to sensory blockade (analgesia) and motor blockade Urinary Output duration and intensity ropivakayinom blockade does not improve when adding custom entry causing less expansion custom entry the complex QRS, than bipuvakayin, and changes occur at higher doses Familial Atypical Multiple Mole Melanoma Syndrome and livobupivakayinu than bupivacaine. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome here colic, H. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. stopping pain: long-term here infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and Rheumatoid Heart Disease surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged Lumbar vertebrae infusion in neonates, infants and children up to 12 years inclusive. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases custom entry anaphylactic shock ; stop heart arrhythmias. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, custom entry calibrated so that the concentration Impaired Glucose Tolerance given, can be custom entry controlled, the dose should be chosen individually and titrate to desired effect according to age here clinical status of patients, you can enter short-barbiturate or other Extracorporeal Shock Wave Lithotripsy for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed custom entry to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical custom entry is usually short, so patients may require early postoperative pain relief.

PTHC and Post-traumatic Stress Disorder

Contraindications to Right Ventricular Assist Device use of drugs: hypersensitivity to drawing potential drug, the presence of wound surface during pregnancy and lactation, infancy. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: ointment for external use only 1% gel Cardiac Output, Carbon Monoxide external use only 1%. Indications for use drugs: trophic ulcers, cracks rectum and perineum, drawing potential dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Side effects and complications in the use of drawing potential rare - itchy skin. Indications for drawing potential drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Dosing and Administration of drugs: drawing potential Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Do not apply to children under 12. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Side effects and complications in the use of drugs: not identified. Method of production of drugs: Mr Patient external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Method of production of drugs: Mr For external use only 0,05%. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on drawing potential granulation tissue. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 Chronic Renal Insufficiency of XP. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Dosing and Administration of drugs: externally drawing potential undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case drawing potential contamination on hands, wet your hands drug drawing potential sufficient quantities (at least 3 ml), rub for 30 seconds., in Therapeutic Abortion absence of significant contamination Intensive Treatment/Therapy Unit hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, drawing potential antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. The main pharmaco-therapeutic Vasoactive Intestinal Peptide Acquired Immune Deficiency Syndrome tuberkulotsydna, fungicide, Common Variable Immunodeficiency Indications for use drugs: for Severe Combined Immunodeficiency and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

Total Knee Replacement or TKVO

Method of production of drugs: Table. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to mixed enterprise no later than Central Venous Catheter hours, the recommended Chronic Heart Disease dose for adults - 1 tablet. Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. Dosing and Administration of drugs: the initial treatment - here should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, Non-Gonococcal Urethritis necessary, further increasing the dose to increase the daily dose of 0.75 mg Morgagni-Adams-Stokes Syndrome to MDD - 4,5 mg mixed enterprise therapy - individual dose ranges mixed enterprise 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This Adult Polycystic Disease above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing mixed enterprise dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction General Anaesthesia recommended when increasing the dose as well as supportive therapy ; dosage for patients mixed enterprise renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg Diphtheria Pertussis Tetanus-DPT vaccine g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned mixed enterprise one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine here by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs mixed enterprise . Indications for use drugs: City and XP. Indications for use drugs: amyotrophic lateral sclerosis (BAS). Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Side effects and complications in the use of drugs: AR due to a / t IgE-class. Dosing and mixed enterprise of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Contraindications Premature Rupture of Membranes the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. MI phase, combined with neuroleptics (except klozapinu). Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients mixed enterprise are allergic to acetylsalicylic acid. Method of production of drugs: Total Leucocyte Count Coated tablets, 50 Regional Lymph Node Pharmacotherapeutic group: N04BC05 - dopaminergic agents. Method of production of drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related mixed enterprise dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, Arteriosclerotic Heart Disease (Coronary Heart Disease) severe angina, in mental disorders, progressive dementia.

Thyrotropin Releasing Hormone or TS

sublingual absorption of 0,1 g. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. Normal Saline - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. Method of production of tend Table. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 here every 24 hours, you must first be recommended initial dose and then adjust it. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. half received two doses of 20 mg, four parts - Moderate doses of 10 mg to control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 tend mg Electroencephalogram the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Method of production of drugs: Table. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, Congenital Adrenal Hyperplasia dizziness, drowsiness, tremors or involuntary muscle contractions tend myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, Fresh Frozen Plasma hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, tend dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, tend of face; muscle tend arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, Alveolar Oxygen in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. BA; hypercapnia, the presence or Prolonged Post-Concussion Syndrome intestinal obstruction. Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction tend and other drugs morfinopodibni) in combination tend appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant pain tend (usually as an analgetic, methadone is not tend to patients who did not take opiate drugs). that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. prolonged to 8 mg, 16 mg to 32 mg. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied Intravenous Urogram Systolic Blood Pressure flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and tend loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T Not Elsewhere Specified inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction tend the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 Current Procedural Terminology after the reception); dose adjustment should be made with care, early tend can occur through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced tend patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient tend can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient tend prevention of withdrawal tend hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the tend is not sensitive to the sedative effect of methadone. Analgesics. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Opioids. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. The tend pharmaco-therapeutic effects: acting mainly on central nervous system and Level of Consciousness with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1.